Islet–immune interactions in type 1 diabetes: the nexus of beta cell destruction
- 14 August 2019
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 198 (3) , 326-340
Abstract
Summary: Recent studies in Type 1 Diabetes (T1D) support an emerging model of disease pathogenesis that involves intrinsic β-cell fragility combined with defects in both innate and adaptive immune cell regulation. This combination of defects induces systematic changes leading to organ-level atrophy and dysfunction of both the endocrine and exocrine portions of the pancreas, ultimately culminating in insulin deficiency and β-cell destruction. In this review, we discuss the animal model data and human tissue studies that have informed our current understanding of the cross-talk that occurs between β-cells, the resident stroma, and immune cells that potentiate T1D. Specifically, we will review the cellular and molecular signatures emerging from studies on tissues derived from organ procurement programs, focusing on in situ defects occurring within the T1D islet microenvironment, many of which are not yet detectable by standard peripheral blood biomarkers. In addition to improved access to organ donor tissues, various methodological advances, including immune receptor repertoire sequencing and single-cell molecular profiling, are poised to improve our understanding of antigen-specific autoimmunity during disease development. Collectively, the knowledge gains from these studies at the islet–immune interface are enhancing our understanding of T1D heterogeneity, likely to be an essential component for instructing future efforts to develop targeted interventions to restore immune tolerance and preserve β-cell mass and function.Keywords
Funding Information
- NIH (P01 AI042288)
- NIH (HIRN UC4 DK104194, R01 DK106191)
- Leona M. and Harry B. Helmsley Charitable Trust
This publication has 117 references indexed in Scilit:
- The Non-Obese Diabetic (NOD) Mouse as a Model of Human Type 1 Diabetes2012
- Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patientsJournal of Experimental Medicine, 2012
- Specificity and detection of insulin-reactive CD4+T cells in type 1 diabetes in the nonobese diabetic (NOD) mouseProceedings of the National Academy of Sciences, 2011
- Innervation Patterns of Autonomic Axons in the Human Endocrine PancreasCell Metabolism, 2011
- STAT1 Is a Master Regulator of Pancreatic β-Cell Apoptosis and Islet InflammationJournal of Biological Chemistry, 2011
- IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cellsJournal of Experimental Medicine, 2010
- Diabetogenic T cells recognize insulin bound to IAg7in an unexpected, weakly binding registerProceedings of the National Academy of Sciences, 2010
- Th1 cytokines promote T-cell binding to antigen-presenting cells via enhanced hyaluronan production and accumulation at the immune synapseCellular & Molecular Immunology, 2010
- Chromogranin A is an autoantigen in type 1 diabetesNature Immunology, 2010
- Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivoNature Immunology, 2009